blisibimod
E2190219
UNEXPLORED
Blisibimod is an experimental monoclonal antibody–based biologic designed to inhibit B-cell activating factor (BAFF) for the treatment of autoimmune diseases such as systemic lupus erythematosus.
All labels observed (1)
| Label | Occurrences |
|---|---|
| blisibimod canonical | 1 |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.